ConductScience.org, home

Paper2522751

Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.

Erlich KS and 7 others. Ann Intern Med, 1989. Cited by 98 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial. Papers, record 2522751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2522751

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
PubMed
Journal
Ann Intern Med
PubMed
Year
1989
PubMed
Publication types
Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
4.13
iCite
Revised in PubMed
2019-06-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Erlich KSK S
2Jacobson MAM A
3Koehler JEJ E
4Follansbee SES E
5Drennan DPD P
6Gooze LL
7Safrin SS
8Mills JJ

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Antiviral AgentsMajor topic
Herpes SimplexMajor topic
Organophosphorus CompoundsMajor topic
Phosphonoacetic AcidMajor topic
Acyclovir
Adult
Drug Resistance, Microbial
Foscarnet
Humans
Infusions, Intravenous
Male
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
5-T32-AI07234NIAID NIH HHSUnited StatesT32AI007234PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
40557131Management of Resistant Herpetic Whitlow: A Case of Recurrent Herpetic Whitlow Resistant to Standard Therapy.Case Rep Dermatol2025https://conductscience.org/library/papers/40557131PubMed
21078929Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21078929PubMed
18750674Dermatology: cutaneous manifestations of human immunodeficiency virus infection.West J Med1989https://conductscience.org/library/papers/18750674PubMed
15673740Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15673740PubMed
12669211[Acyclovir-resistant herpes exulcerans et persistens. Type II].Hautarzt2003https://conductscience.org/library/papers/12669211PubMed
12525428Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.Clin Microbiol Rev2003https://conductscience.org/library/papers/12525428PubMed
10952566Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10952566PubMed
10898688A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10898688PubMed
10602719Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10602719PubMed
9797252Coresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9797252PubMed
9421709What clinicians need to know about antiviral drugs and viral resistance.Infect Dis Clin North Am1997https://conductscience.org/library/papers/9421709PubMed
9010648Drug treatment of HIV-related opportunistic infections.Drugs1997https://conductscience.org/library/papers/9010648PubMed
8794364Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.J Virol1996https://conductscience.org/library/papers/8794364PubMed
8540707Foscarnet alters antidiuretic hormone-mediated transport.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8540707PubMed
7553576Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus.Clin Microbiol Rev1995https://conductscience.org/library/papers/7553576PubMed
7527325Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.Drugs1994https://conductscience.org/library/papers/7527325PubMed
7512902Genital herpes. A guide to pharmacological therapy.Drugs1994https://conductscience.org/library/papers/7512902PubMed
2069375Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2069375PubMed
1828096Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.Klin Wochenschr1991https://conductscience.org/library/papers/1828096PubMed
1576586Antiviral therapy: current concepts and practices.Clin Microbiol Rev1992https://conductscience.org/library/papers/1576586PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2522751

GET https://conductscience.org/api/papers/v1/2522751/authors